Saving erythropoietin by administering l-carnitine?
Recombinant human erythropoietin (rhEpo) is widely used for correction of anaemia in patients with end-stage renal disease (ESRD). In some countries, the cost o
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
01 December 1999
|
| In: |
Nephrology, dialysis, transplantation
Year: 1999, Volume: 14, Issue: 12, Pages: 2819-2821 |
| ISSN: | 1460-2385 |
| DOI: | 10.1093/ndt/14.12.2819 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ndt/14.12.2819 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/ndt/article/14/12/2819/1818737 
|
| Author Notes: | Jürgen Bommer |
| Summary: | Recombinant human erythropoietin (rhEpo) is widely used for correction of anaemia in patients with end-stage renal disease (ESRD). In some countries, the cost o |
|---|---|
| Item Description: | Gesehen am 12.10.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1460-2385 |
| DOI: | 10.1093/ndt/14.12.2819 |